Seelos Therapeutics Inc (NASDAQ:SEEL)
| 0.9241 Delayed Data As of Aug 16 |  -0.0515 / -5.28%Today’s Change | 0.48 Today|||52-Week Range 2.79 | -43.31% Year-to-Date |
Latest SEEL News | Press Releases
No recent news for Seelos Therapeutics Inc.
Today’s Trading
| Previous close | 0.98 |
| Today’s open | 0.97 |
| Day’s range | 0.91 - 0.97 |
| Volume | 743,328 |
| Average volume (3 months) | 1,161,273 |
| Market cap | $100.6M |
Data as of 3:59pm ET, 08/16/2022
Growth & Valuation
| Earnings growth (last year) | -70.31% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.73 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| EQEquillium Inc | -0.03 | -1.18% |
| SLDBSolid Biosciences In... | +0.04 | +4.49% |
| AQBAquaBounty Technolog... | -0.08 | -5.41% |
| CRISCuris Inc | -0.05 | -4.50% |
Data as of 3:59pm ET, 08/16/2022
Financials
| Last reporting date | August 17, 2022 |
| EPS forecast (this quarter) | -$0.18 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$66.0M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
